Search Within

Jamie Erin Chaft

Formats
  1. Meeting Abstract (146)
  2. Journal Article (127)
  3. Review (9)
  4. Editorial (2)
  5. Miscellaneous (2)
  6. Conference Paper (1)
  7. Guidelines (1)
  8. Research Letter (1)
Groups
  1. Department of Medicine (289)
  2. Solid Tumor Oncology Division (289)
  3. Thoracic Oncology (289)
  4. Surgery (112)
  5. Department of Pathology and Laboratory Medicine (96)
  6. GSK Faculty (76)

More Groups

People
  1. Mark Kris (107)
  2. Matthew Hellmann (68)
  3. Andreas Rimner (59)
  4. David Jones (49)
  5. Abraham Wu (47)
  6. Valerie Rusch (47)

More People

Years
  1. 2025 (5)
  2. 2024 (29)
  3. 2023 (28)
  4. 2022 (23)
  5. 2021 (23)
  6. 2020 (20)

More Years

Publications
  1. Journal of Thoracic Oncology (60)
  2. Journal of Clinical Oncology (57)
  3. International Journal of Radiation Oncology, Biology, Physics (25)
  4. Annals of Oncology (13)
  5. Journal of Thoracic and Cardiovascular Surgery (10)
  6. Clinical Cancer Research (9)

More Publications

Publishers
  1. Elsevier Inc. (102)
  2. American Society of Clinical Oncology (61)
  3. American Association for Cancer Research (23)
  4. Oxford University Press (16)
  5. Nature Publishing Group (11)
  6. Mosby Elsevier (10)

More Publishers

Results (289)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Transcriptional profiling of neoantigen specific T cells in resectable NSCLC treated with neoadjuvant anti-PD-1
    Meeting Abstract

    Caushi, J.; Ji, Z.; Zhang, J.; El Asmar, M.; Anagnostou, V.; Cottrell, T.; Chan, H. Y.; Guo, H.; Merghoub, T.; Wolchok, J.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Peripheral T cell repertoire evolution in resectable NSCLC treated with neoadjuvant PD-1 blockade
    Meeting Abstract

    Zhang, J.; Ji, Z.; Caushi, J.; El Asmar, M.; Anagnostou, V.; Cottrell, T.; Chan, H. Y.; Guo, H.; Merghoub, T.; Chaft, J.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Neoadjuvant atezolizumab in resectable NSCLC patients: Immunophenotyping results from the interim analysis of the multicenter trial LCMC3
    Meeting Abstract

    Oezkan, F.; He, K.; Owen, D.; Pietrzak, M.; Cho, J. H.; Kitzler, R.; Pearson, R.; Rusch, V.; Chaft, J.; Suh, R.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Bringing immunotherapy into the curative setting: Emerging data on neoadjuvant strategies
    Meeting Abstract

    Chaft, J.
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Neoadjuvant nivolumab in resectable non-small cell lung cancer: Extended follow-up and molecular markers of response
    Meeting Abstract

    Reuss, J. E.; Smith, K. N.; Anagnostou, V.; Zhang, J.; Zahurak, M.; Caushi, J.; Chan, H. Y.; Guo, H.; Hellmann, M. D.; Pardoll, D. M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Neoadjuvant atezolizumab in resectable non-small cell lung cancer (NSCLC): Interim analysis and biomarker data from a multicenter study (LCMC3)
    Meeting Abstract

    Kwiatkowski, D. J.; Rusch, V. W.; Chaft, J. E.; Johnson, B. E.; Nicholas, A.; Wistuba, I. I.; Merritt, R.; Lee, J. M.; Bunn, P. A.; Tang, Y.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Molecular circulating tumor DNA response to identify long-term survival in patients receiving immunotherapy with initial radiologic stable disease
    Meeting Abstract

    Hellmann, M. D.; Zhang, Q.; Abdullah, S. E.; Chaft, J. E.; Segal, N. H.; Gao, C.; Dennis, P. A.; Higgs, B. W.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Randomized phase II study of adjuvant afatinib for three months versus two years in patients with resected stage I-III EGFR mutant NSCLC
    Meeting Abstract

    Chaft, J. E.; Costa, D. B.; Muzikansky, A.; Shrager, J. B.; Lanuti, M.; Huang, J.; Ramchandran, K.; Rangachari, D.; Huberman, M.; Piotrowska, Z.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Neoadjuvant atezolizumab in resectable NSCLC patients: Updated clinical and immunophenotyping results from a multicenter trial
    Meeting Abstract

    Oezkan, F.; He, K.; Owen, D. H.; Pietrzak, M.; Rusch, V. W.; Chaft, J. E.; Kitzler, R.; Nicholas, A.; Schulze, K.; Johnson, A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Coupling neoantigen specific T cell clonotypes and their molecular phenotypes at the single cell level in resectable anti-PD-1 treated NSCLC
    Meeting Abstract

    Caushi, J. X.; Ji, Z.; Zhang, J.; El Asmar, M.; Anagnostou, V.; Cottrell, T. R.; Chan, H. Y.; Guo, H.; Merghoub, T.; Wolchok, J. D.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save